Clinical trial · Observational
Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes
NCT04961489CI-TRIAL-00052700completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to look at the impact on patient outcomes arising from measures implemented during the COVID-19 pandemic. The information and knowledge from this study will be useful for the management and allocation of hospital resources and patients in tne event of a disease outbreak.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Surgery | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Analysis of patients according to type of surgical procedures, medical condition and dates of surgical treatment retrospectively.
- timeFrame
- 1 Jan - 31 Dec 2017, 1 Jan - 31 Dec 2018, 1 Jan - 31 Dec 2019, 1 Jan - 31 Dec 2020
- description
- These patients are classified according to the institution, type of surgical procedures, the medical condition and the dates of surgical treatment. The study will be compared across four time periods.
- measure
- Comparing surgical indices for high volume cancer and non-cancer diagnoses
- timeFrame
- 1 Jan 2020 - 31 Dec 2020
- description
- The study focus on surgical indices for selected high-volume cancer and non-cancer diagnoses over the period 1st January2020 to 31 December 2020 and compare them with similar indices across the same period of time in the preceding 3 years in particular, for the following surgical procedures: 1. Surgeries for the following cancer diagnoses: 1. breast cancer, \[XIV- N60, no malignancy\], \[Malignant, IINeoplasms- C50\], colorectal cancer, \[C18, 19, 20\], 2. hepatocellular carcinoma, \[C22\] 2. Selected non-cancer surgeries: 1. Cholecystectomy 2. Abdominal hernia repair
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * This study involves the extraction of patient records from the enterprise dataware house. As such, we do not stipulate the age limits. * Patients who had the following surgeries during over the period of 1 Jan 2017 to 31 December 2020 * From the identified surgical procedure type or the following cancer-related procedures: 1. Breast 2. Colon 3. Liver 4. Rectum * Selected non-cancer surgeries: 1. Abdominal Wall 2. Gallbladder * Patients from SGH and its related institute NCC * Only local Singapore Citizens Exclusion Criteria: * No exclusion criteria
References
Publications (2)
- BACKGROUNDMazingi D, Navarro S, Bobel MC, Dube A, Mbanje C, Lavy C. Exploring the Impact of COVID-19 on Progress Towards Achieving Global Surgery Goals. World J Surg. 2020 Aug;44(8):2451-2457. doi: 10.1007/s00268-020-05627-7. PMID 32488665
- BACKGROUNDAl-Jabir A, Kerwan A, Nicola M, Alsafi Z, Khan M, Sohrabi C, O'Neill N, Iosifidis C, Griffin M, Mathew G, Agha R. Impact of the Coronavirus (COVID-19) pandemic on surgical practice - Part 2 (surgical prioritisation). Int J Surg. 2020 Jul;79:233-248. doi: 10.1016/j.ijsu.2020.05.002. Epub 2020 May 12. PMID 32413502